To conduct the study, researchers compared medical records from 154,068 COVID-19 patients in the Veterans Health Administration system to a control group of about 5.6 million people with no evidence of confirmed COVID-19. Overall, COVID-19 patients were 36 percent more likely to experience lingering gastrointestinal problems they didn’t have before their infection, according to the findings. The most common diagnoses were acid-related disorders, including gastroesophageal reflux disease and peptic ulcer disease.
“There seems to be some dysregulation that points to a major imbalance in acid production,” Ziyad Al-Aly, MD, study author and chief of research and development at the VA St .Louis Health Care System, told The New York Times.
Most of the patients in the study contracted COVID-19 in the first year of the pandemic, before vaccines were available. View the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
